Tuesday, April 15, 2008

Dropping GE and ENDP

Dear Diary,

"My 20 Favorites" list is maturing, as I've decided to drop General Electric (GE) and Endo Pharmaceuticals (ENDP) from the list, replacing them with Chattem, Inc. (CHTT) and Amgen (AMGN) for my Buffett reasons.

General Electric (GE) has a problem with Return on Total Capital at 6% and Long term Debt at 10 times its Net Profit Margin.

Endo Pharmaceuticals ( ENDP) will need to replace substantial revenues in the near term, as Lidoderm is going into a generic version, I read.

Gene